We’re exiting our position in a health-care stock to raise some cash

We’re exiting our position in a health-care stock to raise some cash

Shortly after the opening bell, we will be exiting our position in GE Healthcare , selling 550 shares at roughly $65. Following Friday’s trade, Jim Cramer’s Charitable Trust will no longer own a position in GEHC. We’re cutting loose our small position in GE Healthcare and raising some cash following two negative developments over the … Read more

Trump’s tariffs are a new challenge for Big Pharma. Here are the best positioned stocks

Trump’s tariffs are a new challenge for Big Pharma. Here are the best positioned stocks

Long-standing trade agreements have largely sheltered the pharmaceutical industry from tariffs but President Donald Trump’s goal of bringing manufacturing back to the United States has put the industry in the administration’s crosshairs. Trump first floated the idea of imposing tariffs of as much as 25% on imported pharmaceuticals in mid-February. Since then, he has repeated … Read more

We’re buying more shares of 2 stocks as the broader market sinks further

We’re buying more shares of 2 stocks as the broader market sinks further

We’re making our first trades of the week. We are buying 25 shares of Danaher at roughly $207 each. Following Friday’s trade, Jim Cramer’s Charitable Trust will own 550 shares of DHR, increasing its weighting to 3.5% from 3.35%. We are buying 10 shares of Home Depot at roughly $358. Following the trade, the Trust … Read more

Life science stocks are under pressure due to possible NIH funding cuts. What lies ahead for the sector

Life science stocks are under pressure due to possible NIH funding cuts. What lies ahead for the sector

A recent move by the Trump administration to substantially lower funding from the National Institutes of Health for research institutions around the country has investors fearing meaningful losses for life science tools companies. The NIH announced in early February that it would cap research funding at 15% for “indirect costs” – those that aren’t directly … Read more

We are booking profits in a rallying rotation play and buying 2 others on the dip

We are booking profits in a rallying rotation play and buying 2 others on the dip

We are making a handful of more trades Tuesday. Selling 75 shares of GE Healthcare at roughly $86 each; following the trade, Jim Cramer’s Charitable Trust will own 550 shares of GEHC, decreasing its weighting to about 1.43% from about 1.62% We are buying 50 shares of TJX at roughly $116; following the trade, the … Read more

Why nursing homes and hospice are so expensive in the U.S.

Why nursing homes and hospice are so expensive in the U.S.

Baby boomers are about to be the largest generation in American history to hit the long-term care space. Born between 1946 and 1964, as defined by Pew Research, the oldest baby boomers are turning 80 next year. The group is set to flood a senior care space that is already understaffed, underfunded and facing political … Read more

What Cramer wants to hear from Nvidia, Salesforce — plus, Lilly does what no other can

What Cramer wants to hear from Nvidia, Salesforce — plus, Lilly does what no other can

Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Wednesday’s key moments. 1. The broader market rebounded Wednesday, with the S & P 500 and Nasdaq trying to snap their four-day losing streaks. The Dow was on pace for its third straight … Read more